Eye drops of FK506 and FK506 prodrugs based on chitosan to improve solubility and stability

Eye drops of FK506 and FK506 prodrugs based on chitosan to improve solubility and stability

Bibliographic Details
Main Authors:	Young-Guk Na, Si-Kyu Lim, Cheong-Weon Cho
Format:	Article
Language:	English
Published:	Archives of Global Professionals 2012-01-01
Series:	Archives of Pharmacy Practice
Online Access:	http://www.archivepp.com/article.asp?issn=2045-080X;year=2012;volume=3;issue=1;spage=33;epage=33;aulast=Na;type=0

Similar Items

On the neuroprotective actions of FK506
by: Macleod, Malcolm
Published: (2001)

Interactions of FK506 and Rapamycin With FK506 Binding Protein 12 in Opportunistic Human Fungal Pathogens
by: Sandeep Vellanki, et al.
Published: (2020-10-01)

Synthetic studies towards FK-506
by: Stocks, Michael John
Published: (1990)

Allogeneic Hepatocyte Transplantation Using FK 506
by: P.M. Markus, et al.
Published: (1997-01-01)

The Rationale for FK 506 in Inflammatory Bowel Disease
by: James C Reynolds, et al.
Published: (1993-01-01)

Studies directed towards the synthesis of FK-506
by: Smith, Kevin J.
Published: (1993)

Rapid Improvement of Genital Aphthae by Topical FK-506 in
by: Mansoor Karimifar, et al.
Published: (2011-03-01)

Biochemical and biophysical studies of FK506 binding proteins
by: Opamawutthikul, Monluedee
Published: (2005)

Towards the synthesis of the ergot alkaloids and analogues of FK-506
by: Weller, Elizabeth
Published: (2009)

Therapeutic Effects of FK506 on IgA Nephropathy Rat
by: Linting Wei, et al.
Published: (2017-11-01)

Molecular Evolution of the Vertebrate FK506 Binding Protein 25
by: Fei Liu, et al.
Published: (2014-01-01)

FK506 Attenuated Pilocarpine-Induced Epilepsy by Reducing Inflammation in Rats
by: Aihua Wang, et al.
Published: (2019-09-01)

Sarcoma de Kaposi em paciente transplantada renal em uso de Fk-506 Kaposi's Sarcoma in a renal transplant patient receiving Fk-506
by: Jorge David Rocha Zanol, et al.
Published: (2002-12-01)

Histomorphometric study of alveolar bone after therapy with immunosuppressant FK506
by: Rogério Lacerda dos Santos, et al.
Published: (2015-12-01)

An investigation of intumescent pyrotechnics : synthetic studies towards FK506 and morphine
by: Shell, Adrian
Published: (1996)

Effects of the novel anti-T cell agent FK-506 on the immune system
by: Woo, J.
Published: (1990)

Design and synthesis of ligands for the FK506-binding proteins and the serotonin transporter
by: Ranganath, Gopalakrishnan
Published: (2012)

Investigation of the effect of FK506 on protein-protein interaction and processing of APP
by: Fan-Lun Liu, et al.
Published: (2007)

The effects of tacrolimus (FK 506) and Cyclosporine on the micturition function in anesthetized rats
by: Szu-Man, et al.
Published: (2005)

Effects of FK506 (Tacrolimus) on the functional recovery of reanastomosed peripheral nerves
by: Lin, Yi-Ming, et al.
Published: (1998)

Inhibitory effect of plasma FKBP12 on immunosuppressive activity of FK506.
by: Sirakata, Yoshiharu
Published: (2015)

Neuroprotective effect of FK506, an immunosuppressant, on transient global ischemia in gerbil.
by: Tokime, Tomoo
Published: (2015)

FK506 and spinal cord injury : investigating a mechanism of action and developing and instituting a pre-clinical trial protocol to assess FK506 as a neuroprotective agent
by: MacNally, Stephen Paul
Published: (2004)

Development of Novel Small-Molecule Degraders of FK506-Binding Protein 51
by: Mao, Tianqi
Published: (2020)

A case of reversible toxic optic neuropathy from tacrolimus (FK506)
by: Kimberly K. Gokoffski, MD, PhD, et al.
Published: (2020-12-01)

Effects of FK506 on the healing of diaphyseal, critical size defects in the rat femur
by: RE De la Vega, et al.
Published: (2020-10-01)

Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506?
by: Baumgrass Ria, et al.
Published: (2009-10-01)

Impairment of early fracture healing by skeletal muscle trauma is restored by FK506
by: Brady J. Hurtgen, et al.
Published: (2017-06-01)

FK506 biosynthesis is regulated by two positive regulatory elements in <it>Streptomyces tsukubaensis</it>
by: Goranovič Dušan, et al.
Published: (2012-10-01)

The Treatment of Tacrolimus (FK506) for Psoriasis: One Case Report and Literature Analysis
by: Cao Wei-gang, et al.
Published: (2013-12-01)

Tratamiento inmunosupresor de la miastenia gravis con tacrolimus (FK506)
by: Abderrazek, Jamal Azem
Published: (2006)

The mechanism of cardioprotection of the FK506 inhibited calcineurin dephosphorylation in isolated frog heart.
by: Chiu-Yao (Paul)Huang, et al.
Published: (2003)

Effect of FK506 on osteoinduction by recombinant human bone morphogenetic protein-2.
by: Kaihara, Shinji
Published: (2011)

Treatment With Calcineurin Inhibitor FK506 Attenuates Noise-Induced Hearing Loss
by: Zu-Hong He, et al.
Published: (2021-03-01)

Tacrolimus (FK506) causes disease aggravation in models for inherited peripheral myelinopathies
by: Chi Wang Ip, et al.
Published: (2009-02-01)

Genome-wide screening for genes associated with FK506 sensitivity in fission yeast.
by: Yan Ma, et al.
Published: (2011-01-01)

A utilização do tubo de ácido poliglicólico e FK506 na regeneração de nervos periféricos Use of polyglicolic acid tube associated with FK506 in regeneration of peripheral nerves
by: Márcio Paulino Costa, et al.
Published: (2006-01-01)

Induction of Donor Specific Unresponsiveness in Rat Islet Allografts by Intraportal Grafting and FK506
by: Yohichi Yasunami, et al.
Published: (1994-01-01)

Inhibition of Cytokine Production and Cytokine-Stimulated T-Cell Activation by FK506 (Tacrolimus)1
by: Wassim Y. Almawi, et al.
Published: (2001-10-01)

Targeted Therapy for Acute Autoimmune Myocarditis with Nano-Sized Liposomal FK506 in Rats.
by: Keiji Okuda, et al.
Published: (2016-01-01)